Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Receivables - Net (2016 - 2025)

Abeona Therapeutics (ABEO) has 13 years of Receivables - Net data on record, last reported at $3.5 million in Q2 2023.

  • For Q2 2023, Receivables - Net rose 87.27% year-over-year to $3.5 million; the TTM value through Jun 2023 reached $3.5 million, up 87.27%, while the annual FY2021 figure was $3.0 million, N/A changed from the prior year.
  • Receivables - Net reached $3.5 million in Q2 2023 per ABEO's latest filing, up from $1.0 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $7.0 million in Q3 2020 and bottomed at $15000.0 in Q3 2019.
  • Average Receivables - Net over 5 years is $2.1 million, with a median of $1.5 million recorded in 2022.
  • Peak YoY movement for Receivables - Net: plummeted 99.73% in 2019, then surged 46566.67% in 2020.
  • A 5-year view of Receivables - Net shows it stood at $15000.0 in 2019, then soared by 46566.67% to $7.0 million in 2020, then crashed by 57.14% to $3.0 million in 2021, then tumbled by 65.1% to $1.0 million in 2022, then soared by 234.29% to $3.5 million in 2023.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $3.5 million in Q2 2023, $1.0 million in Q3 2022, and $1.9 million in Q2 2022.